Singular Genomics Systems Inc
NASDAQ:OMIC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Singular Genomics Systems Inc
Accounts Payable
Singular Genomics Systems Inc
Accounts Payable Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
Accounts Payable
$2.6m
|
CAGR 3-Years
86%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Payable
$2.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
Danaher Corp
NYSE:DHR
|
Accounts Payable
$1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Payable
$189.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Payable
$461m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Payable
$3.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
See Also
What is Singular Genomics Systems Inc's Accounts Payable?
Accounts Payable
2.6m
USD
Based on the financial report for Dec 31, 2023, Singular Genomics Systems Inc's Accounts Payable amounts to 2.6m USD.
What is Singular Genomics Systems Inc's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
86%
Over the last year, the Accounts Payable growth was -17%. The average annual Accounts Payable growth rates for Singular Genomics Systems Inc have been 86% over the past three years .
You don't have any saved screeners yet
